Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Manger

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2021
Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell DepletionDavid Simon, Koray Tascilar, Katja Schmidt, et al.
Rheumatology (Oxford, England)|April 8, 2021
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA studyVerena Schönau, Jessica Roth, Koray Tascilar, et al.
Arthritis and Rheumatism|April 9, 2005
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Bruce Kirkham, et al.
The Lancet. Infectious Diseases|April 15, 2022
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3Prerna Arora, Lu Zhang, Cheila Rocha, et al.
Lancet (London, England)|March 17, 2023
CD19-targeted CAR T cells in refractory antisynthetase syndromeFabian Müller, Sebastian Boeltz, Johannes Knitza, et al.
Annals of the Rheumatic Diseases|May 7, 2021
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseasesDavid Simon, Koray Tascilar, Filippo Fagni, et al.
Annals of the Rheumatic Diseases|July 29, 2020
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imagingChristian Schmidkonz, Simon Rauber, Armin Atzinger, et al.
The Journal of Rheumatology|April 3, 2008
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases|February 10, 2015
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO studyJudith Haschka, Matthias Englbrecht, Axel J Hueber, et al.
The Journal of Rheumatology|December 4, 2018
Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody StatusMelanie Hagen, Matthias Englbrecht, Judith Haschka, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2021
Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell DepletionDavid Simon, Koray Tascilar, Katja Schmidt, et al.
Rheumatology (Oxford, England)|April 8, 2021
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA studyVerena Schönau, Jessica Roth, Koray Tascilar, et al.
Arthritis and Rheumatism|April 9, 2005
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Bruce Kirkham, et al.
The Lancet. Infectious Diseases|April 15, 2022
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3Prerna Arora, Lu Zhang, Cheila Rocha, et al.
Lancet (London, England)|March 17, 2023
CD19-targeted CAR T cells in refractory antisynthetase syndromeFabian Müller, Sebastian Boeltz, Johannes Knitza, et al.
Annals of the Rheumatic Diseases|May 7, 2021
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseasesDavid Simon, Koray Tascilar, Filippo Fagni, et al.
Annals of the Rheumatic Diseases|July 29, 2020
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imagingChristian Schmidkonz, Simon Rauber, Armin Atzinger, et al.
The Journal of Rheumatology|April 3, 2008
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases|February 10, 2015
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO studyJudith Haschka, Matthias Englbrecht, Axel J Hueber, et al.
The Journal of Rheumatology|December 4, 2018
Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody StatusMelanie Hagen, Matthias Englbrecht, Judith Haschka, et al.
Pageof 14